Revelation Biosciences Stock Fundamentals
| REVBW Stock | USD 0.02 0.00 0.00% |
Revelation Biosciences fundamentals help investors to digest information that contributes to Revelation Biosciences' financial success or failures. It also enables traders to predict the movement of Revelation Stock. The fundamental analysis module provides a way to measure Revelation Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Revelation Biosciences stock.
At this time, Revelation Biosciences' Total Operating Expenses is fairly stable compared to the past year. Depreciation And Amortization is likely to climb to about 38 K in 2025, despite the fact that Operating Income is likely to grow to (7.6 B). Revelation | Select Account or Indicator |
Revelation Biosciences Company Return On Equity Analysis
Revelation Biosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Revelation Biosciences Return On Equity | -2.65 |
Most of Revelation Biosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Revelation Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Revelation Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Revelation Biosciences has a Return On Equity of -2.6485. This is 88.95% lower than that of the Biotechnology sector and 92.74% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Revelation Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Revelation Biosciences's current stock value. Our valuation model uses many indicators to compare Revelation Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Revelation Biosciences competition to find correlations between indicators driving Revelation Biosciences's intrinsic value. More Info.Revelation Biosciences is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At this time, Revelation Biosciences' Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Revelation Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Revelation Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Revelation Biosciences' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Revelation Biosciences could also be used in its relative valuation, which is a method of valuing Revelation Biosciences by comparing valuation metrics of similar companies.Revelation Biosciences is currently under evaluation in return on equity category among its peers.
Revelation Fundamentals
| Return On Equity | -2.65 | ||||
| Return On Asset | -0.53 | ||||
| Number Of Shares Shorted | 14.14 K | ||||
| EBITDA | (7.98 B) | ||||
| Net Income | (15.04 B) | ||||
| Cash And Equivalents | 4.14 M | ||||
| Cash Per Share | 1.79 X | ||||
| Total Debt | 1.91 B | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 2.58 X | ||||
| Book Value Per Share | 9.02 X | ||||
| Cash Flow From Operations | (18.32 B) | ||||
| Earnings Per Share | (4.77) X | ||||
| Beta | 0.18 | ||||
| Total Asset | 6.62 B | ||||
| Retained Earnings | (40.51 B) | ||||
| Working Capital | 4.65 M | ||||
| Net Asset | 6.62 B |
About Revelation Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Revelation Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revelation Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revelation Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 2.6 M | 2.3 M | |
| Cost Of Revenue | 22.5 K | 35.8 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.